시장개요
Between 2026 그리고 2031, the Thailand digestive and intestinal remedies industry is expected to generate USD 38.1 million in incremental growth, corresponding to a CAGR of approximately 6.14% over the period. The market’s momentum is being shaped by a broader reassessment of gut health, as consumers connect digestive discomfort with stress, irregular meals, sedentary routines and heavier exposure to processed, spicy or fried foods. This is keeping demand resilient for over-the-counter remedies, particularly among urban consumers seeking fast relief for symptoms that increasingly fit into daily lifestyle patterns rather than isolated episodes.
Thailand’s ageing population and return-to-office routines are adding further depth to demand for acid-related treatments, with antacids and proton pump inhibitors positioned to capture some of the strongest growth. Antacids benefit from high consumer familiarity and immediate-use positioning, while proton pump inhibitors are gaining ground as pharmacists steer reflux and acid-related complaints toward longer-lasting treatment options. As awareness of gastroesophageal reflux and heartburn rises, consumers are likely to trade up from basic symptom relief toward products that promise stronger efficacy, easier dosing and more convenient formats.
Health consciousness will also complicate the category’s growth path. More consumers are trying to prevent digestive problems through diet, exercise, probiotics, prebiotics and traditional ingredients such as ginger, turmeric and galangal, which could moderate reliance on conventional remedies. At the same time, this preventive mindset gives manufacturers room to move beyond single-function relief, encouraging formulations that combine acid control with broader wellness cues, natural positioning or gut-support benefits. The boundary between digestive remedies and functional nutrition is likely to become less distinct as consumers look for products that feel both therapeutic and preventive.
Distribution is becoming a more important growth lever as digestive remedies move further beyond the pharmacy counter. Pharmacies will retain their central role because pharmacist advice remains influential in product selection, especially for acid reflux, diarrhoeal remedies and recurring stomach complaints. Convenience stores and online channels, however, are gaining relevance by serving immediate, on-the-go demand through sachets, small packs and fast-acting formats. For a category often triggered by acute discomfort after meals or during travel, broader availability may increasingly convert digestive remedies from planned healthcare purchases into impulse-driven essentials.
Providing a strategic perspective on the Thailand digestive and intestinal remedies market, this report analyzes historical trends from 2021 onward and forecasts market developments through 2031. It delves into market size, 성장률, and segment-level insights, uncovering the forces shaping the industry’s future. By examining product type, 유형, age group and distribution channel, the report delivers a robust framework for understanding market dynamics and identifying pathways for growth.
보고서 내용
Designed for business leaders and strategists, this report offers a data-rich overview of the Thailand digestive and intestinal remedies market from 2021 에게 2031, including historical data and projections through 2031. All figures are reported in (THB/USD), 복합 연간 성장률로 (CAGR) calculated for both periods. The analysis spans key dimensions such as product type, 유형, age group and distribution channel. This structure enables decision-makers to isolate growth-driving segments and align resource allocation with emerging market opportunities.
In addition to market size data, the report also delves into the key factors driving market evolution. Based on industry interviews and authoritative macroeconomic data, the report analyzes the key drivers behind market size fluctuations and outlines future development trends. It integrates insights on innovation, shifts in consumer behavior, and environmental changes to dissect market growth drivers and potential risks. Special focus is placed on high-performing growth areas within sub-markets, as well as opportunities arising from product innovations.
이 보고서는 또한 다음과 같은 주요 기업 간의 시장 점유율 변화와 핵심 브랜드 성과에 대한 포괄적인 평가를 제공합니다. 2021 가장 최근 기간까지. 경쟁 역학과 시장 집중 추세를 보여줍니다., 세분화된 시장 점유율 비교 및 추세 분석 제공. 이를 통해 사용자는 경쟁 우위와 과제를 더 잘 이해할 수 있습니다., 이를 통해 강력한 실증적 증거를 바탕으로 차별화된 시장 전략과 투자 결정을 제공합니다..
시장 세분화
The Thailand digestive and intestinal remedies market is structured as follows:
제품 유형 – 예를 들어, antacids, anti-diarrheal products, antiflatulents, digestive enzymes, H2 blockers, laxatives, motion sickness remedies, proton pump inhibitors (PPIs)
유형 – 예를 들어, herbal and traditional remedies, modern medicines
Age group – 예를 들어, adult and geriatric, pediatirc
유통채널 – 예를 들어, 편의점, 전자상거래, 대형마트, pharmacies/personal care stores, 작은 식료품점, 슈퍼마켓, 다른 사람
거시경제 & 인구통계학적 지표
지원 컨텍스트에는 다음이 포함됩니다.:
총인구
소비자물가지수 (CPI)
국내 총생산 (GDP)
1인당 소비량
GDP 대비 소비자 지출 비율
이러한 변수는 시장에 영향을 미치는 소비 잠재력과 거시 경제 동향에 대한 이해를 향상시킵니다..
경쟁 환경: 시장 점유율 분석
Alongside sizing and segmentation data, the report includes market share breakdowns for primary players in the digestive and intestinal remedies market in Thailand, highlighting dominant firms and brand-level movements. Companies profiled include: Baihor Brand Dispensary Company Limited, Bangkok Lab and Cosmetic Public Company Limited, Berlin Pharmaceutical Industry Co., Ltd., Boss Pharmacare Co., Ltd., Brywood Pharmaceutical Co., Ltd., Celltrion Inc., Daiichi Sankyo Company, Limited, Haleon plc, Kenvue Inc., Lee Buan Soa Dispensary (Hangkao) Co., Ltd., Opella Healthcare Group SAS, 레킷벤키저그룹 plc (RB), RX Co., Ltd., Seven Stars Pharmaceutical Co., Ltd., Thai Nakorn Patana Co., Ltd., The Government Pharmaceutical Organization, 프록터 & 도박 회사 (피&G), Unison Laboratories Co., Ltd., 등.
Market share data is presented for top-performing companies in the overall digestive and intestinal remedies sector, as well as for individual segments such as digestive and intestinal remedies, antacids, anti-diarrheal products, antiflatulents, digestive enzymes, H2 blockers, laxatives, motion sickness remedies, proton pump inhibitors (PPIs) and paediatric digestive and intestinal remedies, enabling a granular view of competitive dynamics.
보고서에서 다루는 시장 점유율 분석:
Thailand digestive and intestinal remedies market share
Thailand antacids market share
Thailand anti-diarrheal products market share
Thailand antiflatulents market share
Thailand digestive enzymes market share
Thailand H2 blockers market share
Thailand laxatives market share
Thailand motion sickness remedies market share
Thailand proton pump inhibitors (PPIs) market share
Thailand paediatric digestive and intestinal remedies market share
이 보고서를 선택하는 이유?
Designed as a concise yet in-depth data snapshot, this publication is tailored for professionals seeking accurate, timely, and actionable quantitative insights. Whether you’re a market entrant, investor, or established player, 이 보고서는 확실한 비즈니스 의사결정을 자신 있게 지원하도록 작성되었습니다..
구매하기 전에 데이터 구조와 프리젠테이션 품질을 미리 볼 수 있도록 수정된 샘플을 요청하세요..
결과물에는 다음이 포함됩니다.
전문적으로 구성된 PDF 보고서
연도별 수치와 다차원 분할이 포함된 전체 EXCEL 데이터북 2021 에게 2031
목차
목차
시장 세분화
시장개요
Thailand Digestive and Intestinal Remedies Market – 제품 유형 분석
Thailand Digestive and Intestinal Remedies Market – 유형 분석
Thailand Digestive and Intestinal Remedies Market – Age Group Analysis
Thailand Digestive and Intestinal Remedies Market – 유통채널 분석
기업/브랜드 점유율 분석
Baihor Brand Dispensary Company Limited
Bangkok Lab and Cosmetic Public Company Limited
Berlin Pharmaceutical Industry Co., 주식회사.
Boss Pharmacare Co., 주식회사.
Brywood Pharmaceutical Co., 주식회사.
…
거시경제 데이터 및 예측
연구 방법론
부인 성명
그림과 표
Table Thailand Digestive and Intestinal Remedies Market 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market, 순증가, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market, 성장률, 2021-2031
Table Thailand Digestive and Intestinal Remedies Market by Product Type, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Product Type, CAGR 역사 및 예측, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Product Type, 2021-2031
Table Thailand Digestive and Intestinal Remedies Market by Type, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Type, CAGR 역사 및 예측, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Type, 2021-2031
Table Thailand Digestive and Intestinal Remedies Market by Age Group, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Age Group, CAGR 역사 및 예측, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Age Group, 2021-2031
Table Thailand Digestive and Intestinal Remedies Market by Distribution Channel, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Distribution Channel, CAGR 역사 및 예측, 2021-2031
Chart Thailand Digestive and Intestinal Remedies Market by Distribution Channel, 2021-2031
Table Thailand Digestive and Intestinal Remedies Market Share (%), 회사별, 2021-2025
Chart Thailand Digestive and Intestinal Remedies Market, 회사별, 2025
Table Thailand Digestive and Intestinal Remedies Market Share (%), 브랜드별, 2021-2025
Chart Thailand Digestive and Intestinal Remedies Market, 브랜드별, 2025
Table Thailand – 인구 (수백만) 및 예측
Table Thailand – 소비자물가지수 (CPI) 및 예측
Table Thailand – 국내총생산(GDP)과 전망
Table Thailand Digestive and Intestinal Remedies Market: GDP 대비 지출 (%)
Table Thailand Digestive and Intestinal Remedies Market: 1인당 소비 (인구)
언급된 회사
This report profiles the following Thailand Digestive and Intestinal Remedies companies:
Baihor Brand Dispensary Company Limited
Bangkok Lab and Cosmetic Public Company Limited
Berlin Pharmaceutical Industry Co., 주식회사.
Boss Pharmacare Co., 주식회사.
Brywood Pharmaceutical Co., 주식회사.
Celltrion Inc.
Daiichi Sankyo Company, Limited
Haleon plc
Kenvue Inc.
Lee Buan Soa Dispensary (Hangkao) Co., 주식회사.
Opella Healthcare Group SAS
레킷벤키저그룹 plc (RB)
RX Co., 주식회사.
Seven Stars Pharmaceutical Co., 주식회사.
Thai Nakorn Patana Co., 주식회사.
The Government Pharmaceutical Organization
프록터 & 도박 회사 (피&G)
Unison Laboratories Co., 주식회사.
